Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies
Naidoo, J., Page, D.B., Li, B.T., Connell, L.C., Schindler, K., Lacouture, M.E., Postow, M.A., Wolchok, J.D.
Published in Annals of oncology (01.12.2015)
Published in Annals of oncology (01.12.2015)
Get full text
Journal Article
Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor
Belum, V.R, Benhuri, B, Postow, M.A, Hellmann, M.D, Lesokhin, A.M, Segal, N.H, Motzer, R.J, Wu, S, Busam, K.J, Wolchok, J.D, Lacouture, M.E
Published in European journal of cancer (1990) (01.06.2016)
Published in European journal of cancer (1990) (01.06.2016)
Get full text
Journal Article
Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines
Lacouture, M.E., Sibaud, V., Gerber, P.A., van den Hurk, C., Fernández-Peñas, P., Santini, D., Jahn, F., Jordan, K.
Published in Annals of oncology (01.02.2021)
Published in Annals of oncology (01.02.2021)
Get full text
Journal Article
Regorafenib-associated hand–foot skin reaction: practical advice on diagnosis, prevention, and management
McLellan, B., Ciardiello, F., Lacouture, M.E., Segaert, S., Van Cutsem, E.
Published in Annals of oncology (01.10.2015)
Published in Annals of oncology (01.10.2015)
Get full text
Journal Article
Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies
Naidoo, J, Page, D B, Li, B T, Connell, L C, Schindler, K, Lacouture, M E, Postow, M A, Wolchok, J D
Published in Annals of oncology (01.07.2016)
Published in Annals of oncology (01.07.2016)
Get full text
Journal Article
Immune‐related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
Zarbo, A., Belum, V.R., Sibaud, V., Oudard, S., Postow, M.A., Hsieh, J.J., Motzer, R.J., Busam, K.J., Lacouture, M.E.
Published in British journal of dermatology (1951) (01.06.2017)
Published in British journal of dermatology (1951) (01.06.2017)
Get full text
Journal Article
Validation and responsiveness of the English version of the Chemotherapy-Induced Alopecia Distress Scale (CADS) in breast cancer patients
Kraehenbuehl, L., Kang, D., Bang, A. S., Ketosugbo, K. F., Hay, J., Patil, Sujata, Goldfarb, S., Cho, J., Lacouture, M. E.
Published in Supportive care in cancer (01.06.2024)
Published in Supportive care in cancer (01.06.2024)
Get full text
Journal Article
Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group
Puzanov, I, Diab, A, Abdallah, K, Bingham, 3rd, C O, Brogdon, C, Dadu, R, Hamad, L, Kim, S, Lacouture, M E, LeBoeuf, N R, Lenihan, D, Onofrei, C, Shannon, V, Sharma, R, Silk, A W, Skondra, D, Suarez-Almazor, M E, Wang, Y, Wiley, K, Kaufman, H L, Ernstoff, M S
Published in Journal for immunotherapy of cancer (21.11.2017)
Published in Journal for immunotherapy of cancer (21.11.2017)
Get full text
Journal Article
European recommendations for management of immune checkpoint inhibitors‐derived dermatologic adverse events. The EADV task force ‘Dermatology for cancer patients’ position statement
Apalla, Z., Nikolaou, V., Fattore, D., Fabbrocini, G., Freites‐Martinez, A., Sollena, P., Lacouture, M., Kraehenbuehl, L., Stratigos, A., Peris, K., Lazaridou, E., Richert, B., Vigarios, E., Riganti, J., Baroudjian, B., Filoni, A., Dodiuk‐Gad, R., Lebbé, C., Sibaud, V.
Published in Journal of the European Academy of Dermatology and Venereology (01.03.2022)
Published in Journal of the European Academy of Dermatology and Venereology (01.03.2022)
Get full text
Journal Article
IgE blockade with omalizumab reduces pruritus related to immune checkpoint inhibitors and anti-HER2 therapies
Barrios, D.M., Phillips, G.S., Geisler, A.N., Trelles, S.R., Markova, A., Noor, S.J., Quigley, E.A., Haliasos, H.C., Moy, A.P., Schram, A.M., Bromberg, J., Funt, S.A., Voss, M.H., Drilon, A., Hellmann, M.D., Comen, E.A., Narala, S., Patel, A.B., Wetzel, M., Jung, J.Y., Leung, D.Y.M., Lacouture, M.E.
Published in Annals of oncology (01.06.2021)
Published in Annals of oncology (01.06.2021)
Get full text
Journal Article
A dosing/cross-development study of the multikinase inhibitor sorafenib in patients with pulmonary arterial hypertension
Gomberg-Maitland, M, Maitland, M L, Barst, R J, Sugeng, L, Coslet, S, Perrino, T J, Bond, L, Lacouture, M E, Archer, S L, Ratain, M J
Published in Clinical pharmacology and therapeutics (01.03.2010)
Published in Clinical pharmacology and therapeutics (01.03.2010)
Get more information
Journal Article
Oral lichenoid reactions associated with anti‐PD‐1/PD‐L1 therapies: clinicopathological findings
Sibaud, V., Eid, C., Belum, V.R., Combemale, P., Barres, B., Lamant, L., Mourey, L., Gomez‐Roca, C., Estilo, C.L., Motzer, R., Vigarios, E., Lacouture, M.E.
Published in Journal of the European Academy of Dermatology and Venereology (01.10.2017)
Published in Journal of the European Academy of Dermatology and Venereology (01.10.2017)
Get full text
Journal Article
The microbial flora of clinically infected cutaneous metastases: a retrospective study
Virgen, C. A., Barker, C. A., Lacouture, M. E.
Published in Clinical and experimental dermatology (01.08.2020)
Published in Clinical and experimental dermatology (01.08.2020)
Get full text
Journal Article
Olmutinib‐induced palmoplantar keratoderma
Chen, K.L., Cho, Y.T., Yang, C.W., Sheen, Y.S., Liang, C.W., Lacouture, M.E., Chu, C.Y.
Published in British journal of dermatology (1951) (01.02.2018)
Published in British journal of dermatology (1951) (01.02.2018)
Get full text
Journal Article
A phase II study (ARCHER 1042) to evaluate prophylactic treatment of dacomitinib-induced dermatologic and gastrointestinal adverse events in advanced non-small-cell lung cancer
Lacouture, M.E., Keefe, D.M., Sonis, S., Jatoi, A., Gernhardt, D., Wang, T., Doherty, J.P., Giri, N., Nadanaciva, S., O'Connell, J., Sbar, E., Piperdi, B., Garon, E.B.
Published in Annals of oncology (01.09.2016)
Published in Annals of oncology (01.09.2016)
Get full text
Journal Article